GAMMA Investing’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

GAMMA Investing’s Portfolio CMAX Stock Details CMAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-83	Closed	-$400	–	3555
2024 Q1	$400	Buy	+83	New	+$697	﹤0.01%	3138

Other funds holding CMAX

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GAMMA Investing's CMAX Position: Q2 2024 in Review

GAMMA Investing sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q2 2024, closing a stake of 83 shares — an estimated $400 sold.

GAMMA Investing first reported a position in CMAX in Q1 2024 and held it in 1 quarter. The position peaked at $400 in Q1 2024. 40 funds tracked by Wall St. Rank hold CMAX as of Q2 2024.

GAMMA Investing reported no remaining CareMax, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
GAMMA Investing sold 83 CareMax, Inc. Class A Common Stock shares in Q2 2024, an estimated $400.
GAMMA Investing first reported a position in CareMax, Inc. Class A Common Stock in Q1 2024 and held it in 1 quarter.
GAMMA Investing's CareMax, Inc. Class A Common Stock position peaked at $400 in Q1 2024.
40 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q2 2024.

Based on GAMMA Investing's 13F filing for Q2 2024, filed 2 Jul 2024.